Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.410 +0.120 (+3.65%)

Streaming Delayed Price Updated: 3:57 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

22 23 Next >

Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy? ↗

April 04, 2024

This stock's upside is huge, but so is its downside.

Via The Motley Fool

Topics Artificial Intelligence

Recursion to Participate in Upcoming Investor Conference

April 02, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

AI Sector Stalling: Only 4 Of 7 Categories Went Up In March ↗

March 31, 2024

No AI category went down in February, but 3 did in March - confirming my comment last week that

Via Talk Markets

Topics Artificial Intelligence

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares ↗

March 26, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Recursion Pharmaceuticals ↗

March 04, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

Recursion Publishes Annual Environmental, Social and Governance Report

March 26, 2024

Provides progress updates in support of long-term commitments focused on reducing greenhouse gas emissions, improving workforce diversity and accelerating community impact.

From Recursion Pharmaceuticals

Via GlobeNewswire

Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships ↗

March 25, 2024

Nvidia announces partnerships with J&J and GE Healthcare to integrate generative AI into surgery and medical imaging at GTC AI conference. Analysts see potential for revenue growth outside tech sector....

Via Benzinga

Topics Artificial Intelligence

New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence ↗

March 18, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision ↗

March 11, 2024

Additionally, the investments help Nvidia "build out the future ecosystem of businesses that depend on its technology" even as rivals are trying to break into the chipmaker's dominance.

Via Benzinga

Topics Artificial Intelligence

Recursion Announces Plans to Open New Office in London

March 11, 2024

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the...

From Recursion Pharmaceuticals, Inc.

Via GlobeNewswire

Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst ↗

March 07, 2024

The company just made a provocative move in one of its collaborations.

Via The Motley Fool

The Top 7 Small-Cap Stocks to Buy in March 2024 ↗

March 04, 2024

These top small-cap stocks to buy are set for a strong 2024 as reduced inflation increases their growth prospects.

Via InvestorPlace

Topics Economy

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community

March 01, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗

March 01, 2024

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Via InvestorPlace

Recursion to Participate in Upcoming Investor Conferences

March 01, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today ↗

February 28, 2024

The company had attracted much interest due to its heavy use of artificial intelligence, but its latest fundamentals disappointed many.

Via The Motley Fool

Topics Artificial Intelligence

Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2024

Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-expected sales for its fourth quarter.

Via Benzinga

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

3D Systems Posts Downbeat Q4 Results, Joins Eventbrite, Lemonade And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

February 28, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Wednesday.

Via Benzinga

Topics Stocks

What's Going On With Recursion Pharmaceuticals Stock Tuesday? ↗

February 27, 2024

Recursion reported fourth-quarter revenue of $10.89 million, which missed the consensus estimate of $20.35 million. The clinical stage biotech company reported a quarterly loss of 42 cents per share,...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 27, 2024

Via Benzinga

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 27, 2024

From Recursion Pharmaceuticals

Via GlobeNewswire

10+ Stocks, ETFs To Ride On Nvidia's Record-Breaking Success ↗

February 22, 2024

Shares of NVIDIA Corp rose 15% as quarterly earnings beat forecasts. CEO cites AI's role in company's growth. Tech sector up. ETFs benefit.

Via Benzinga

Topics Artificial Intelligence ETFs Earnings

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours? ↗

February 22, 2024

These companies are focused on next-gen technologies that could help transform the healthcare industry.

Via The Motley Fool

NVIDIA Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

February 21, 2024

NVIDIA Corporation (NASDAQ: NVDA) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 21, 2024.

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.